Patent Applications published on Aug 31, 2023 - page 3

#601
US20230270635A1
Human necessities

METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS

#602
US20230270636A1
Human necessities

GOLD AND PALMITOYL PENTAPEPTIDE-4 NANOPARTICLES

#603
US20230270637A1
Human necessities

Oral Care Compositions

#604
US20230270638A1
Human necessities

Zinc Phosphate Containing Compositions

#605
US20230270639A1
Human necessities

Metal Oxide Sunscreen Formulations

#606
US20230270640A1
Human necessities

BRIGHTENING COSMETIC COMPOSITION COMPRISING SODIUM PYRUVATE AS ACTIVE INGREDIENT

#607 ✅ Patent 12,268,767 granted on 2025-04-08
US20230270641A1
Human necessities

Compositions and methods for treating hair

#608
US20230270642A1
Human necessities

AQUEOUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS COMPRISING A FATTY ACID MONOESTER, A FATTY ACID SALT, A PULLULAN AND A POLYOL

#609
US20230270643A1
Human necessities

DYEING AND/OR LIGHTENING COMPOSITION COMPRISING AN ANTHRAQUINONE CATIONIC DIRECT DYE, A FATTY SUBSTANCE, A CHEMICAL OXIDIZING AGENT AND A BASIFYING AGENT AND/OR AN OXIDATION DYE PRECURSOR

#610
US20230270644A1
Human necessities

COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS

#611
US20230270645A1
Human necessities

COSMETIC SUNSCREEN COMPOSITION, PROCESS FOR MANUFACTURING A COSMETIC SUNSCREEN COMPOSITION AND USE OF A COSMETIC SUNSCREEN COMPOSITION

#612 ✅ Patent 12,102,703 granted on 2024-10-01
US20230270646A1
Human necessities

Hair dyeing composition comprising blue dyes

#613 ✅ Patent 12,097,274 granted on 2024-09-24
US20230270647A1
Human necessities

Oxidative dyeing agent for keratin fibers comprising novel dye precursor combinations

#614 ✅ Patent 12,102,704 granted on 2024-10-01
US20230270648A1
Human necessities

Oxidative dyeing agent for keratin fibers comprising novel dye precursor combinations

#615 ✅ Patent 12,178,897 granted on 2024-12-31
US20230270649A1
Human necessities

Oxidative dyeing agent for keratin fibers comprising novel dye precursor combinations

#616
US20230270650A1
Human necessities

CANNABIS-BASED PRODUCTS AND METHODS

#617
US20230270651A1
Human necessities

HAIR CARE COMPOSITION CONTAINING POLYMERIC COLORANT

#618 ✅ Patent 12,201,712 granted on 2025-01-21
US20230270652A1
Human necessities

Method for dyeing keratinous material, comprising the use of an organosilicon compound, a phosphoric acid ester and a dyeing compound

#619
US20230270653A1
Human necessities

USE OF TREHALOSE FOR INHIBITING AILMENT INDUCING MICROORGANISMS

#620 ✅ Patent 11,957,777 granted on 2024-04-16
US20230270654A1
Human necessities

Compositions comprising reaction products of saccharide polymers and fatty esters formulated with a neutral surfactant

#621
US20230270655A1
Human necessities

PERSONAL CARE COMPOSITION AND USAGE METHOD THEREOF

#622
US20230270656A1
Human necessities

AEROSOL HAIR CARE PRODUCT

#623
US20230270657A1
Human necessities

Halogenated Xanthene-Containing Topical Anti-Gram-Positive Bacterial Ophthalmic Composition and Method

#624 ✅ Patent 12,042,556 granted on 2024-07-23
US20230270658A1
Human necessities

Oxidative hair cream composition containing polymeric colorant

#625
US20230270659A1
Human necessities

PHOTOCURABLE RESIN COMPOSITION FOR NAIL OR ARTIFICIAL NAIL, CURED PRODUCT, AND METHOD FOR COATING NAIL OR ARTIFICIAL NAIL

#626
US20230270660A1
Human necessities

Silybum marianum (L.) Gaertn. oil for reinforcing the barrier function of the skin

#627 ✅ Patent 11,793,745 granted on 2023-10-24
US20230270661A1
Human necessities

Topical skin treatment

#628 ✅ Patent 11,896,709 granted on 2024-02-13
US20230270662A1
Human necessities

Natural vegetable source based hair colour

#629
US20230270663A1
Human necessities

FORMULATION FOR THE TREATMENT OF FINE LINES AND WRINKLES AND USES THEREOF

#630
US20230270664A1
Human necessities

DELIVERY DEVICE

#631
US20230270665A1
Human necessities

RAPIDLY-ORODISPERSIBLE TABLETS HAVING AN INTERIOR CAVITY

#632
US20230270666A1
Human necessities

NOVEL GASTRORETENTIVE EXTENDED RELEASE DOSAGE FORM

#633
US20230270667A1
Human necessities

CANNABIDIOL INFUSED CANDLE

#634
US20230270668A1
Human necessities

DRY FORMULATIONS OF ANTI-SARS-COV-2 VIRUS ANTIBODIES AND COMPOSITIONS AND METHODS OF USE THEREOF

#635
US20230270669A1
Human necessities

PHARMACEUTICAL COMPOSITION

#636
US20230270670A1
Human necessities

OPHTHALMIC LIQUID COMPOSITION

#637
US20230270671A1
Human necessities

PHARMACEUTICALLY STABLE PILOCARPINE FORMULATIONS WITH SUBSTANTIALLY REDUCED BUFFER CONTENT AND RELATED METHODS

#638
US20230270672A1
Human necessities

MICROEMULSION DRUG DELIVERY SYSTEM FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME

#639 ✅ Patent 11,980,687 granted on 2024-05-14
US20230270673A1
Human necessities

Liposomal compounds and methods of use thereof

#640
US20230270674A1
Human necessities

TARGETED DELIVERY OF EXTRACELLULAR VESICLES

#641
US20230270675A1
Human necessities

ADJUVANTED VACCINE COMPOSITION AND METHODS

#642
US20230270676A1
Human necessities

RAPAMYCIN (RAPA) FORMULATION AND PREPARATION METHOD THEREOF

#643
US20230270677A1
Human necessities

LONG-ACTING THERAPEUTIC AGENT COMBINATIONS AND METHODS THEREOF

#644
US20230270678A1
Human necessities

PHARMACEUTICAL COMPOSITIONS FOR IMPROVED DELIVERY OF THERAPEUTIC LIPOPHILIC ACTIVES

#645
US20230270679A1
Human necessities

METHOD FOR THE PRODUCTION OF BIOCOMPATIBLE NANOMATERIALS WITH SELECTIVE RECOGNITION CAPABILITIES AND USES THEREOF

#646
US20230270680A1
Human necessities

BIOACTIVATABLE DEVICES AND RELATED METHODS

#647
US20230270681A1
Human necessities

DRUG DELIVERY AGENTS FOR PREVENTION OR TREATMENT OF PULMONARY DISEASE

#648
US20230270683A1
Human necessities

TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS

#649 ✅ Patent 11,826,472 granted on 2023-11-28
US20230270684A1
Human necessities

Tamper resistant dosage forms

#650
US20230270685A1
Human necessities

POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASE

#651
US20230270686A1
Human necessities

RECOMBINANT GAS VESICLE NANOPARTICLES

#652
US20230270687A1
Human necessities

HOMEOPATHIC ANTIVIRAL HYDROGEL PATCHES

#653
US20230270688A1
Human necessities

SELF-ADHESIVE PATCHES MADE OF FIBRES FOR THE CONTROLLED RELEASE OF BIOACTIVES

#654
US20230270689A1
Human necessities

TREATMENT OF ALZHEIMER'S DISEASE

#655
US20230270690A1
Human necessities

ORAL COMPOSITIONS

#656
US20230270691A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING INSOLUBLE ACTIVE INGREDIENTS

#657
US20230270692A1
Human necessities

COMPOUNDS FOR CHRONIC DISORDERS

#658
US20230270693A1
Human necessities

Molecular Targets for Modulation of Dissociative and Associative States

#659
US20230270694A1
Human necessities

REDUCED SEDATION AND DISSOCIATION IN TREATING NEUROLOGICAL DISORDERS

#660
US20230270695A1
Human necessities

COMPOUND AND COMPOSITION FOR INDUCING NEUROPROTECTION

#661
US20230270696A1
Human necessities

MEDICINAL USE OF FINGOLIMOD IN PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES CAUSED BY SPHINGOLIPID DISORDERS

#662 ✅ Patent 11,944,594 granted on 2024-04-02
US20230270697A1
Human necessities

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

#663 ✅ Patent 11,944,595 granted on 2024-04-02
US20230270698A1
Human necessities

Treatment or prevention of cardiovascular events via the administration of a colchicine derivative

#664 ✅ Patent 12,285,392 granted on 2025-04-29
US20230270699A1
Human necessities

Method for modulating metabolism

#665
US20230270700A1
Human necessities

PHARMACOLOGY OF VISUAL CYCLE MODULATORS

#666 ✅ Patent 12,274,681 granted on 2025-04-15
US20230270701A1
Human necessities

Compositions and methods for reducing skin fat

#667 ✅ Patent 12,257,217 granted on 2025-03-25
US20230270702A1
Human necessities

Compositions and methods for treating hyperphagia in prader-willi syndrome

#668
US20230270703A1
Human necessities

COMPOUNDS AND METHODS FOR THE TREATMENT OF EYE DISORDERS

#669
US20230270704A1
Human necessities

AMINOACIDS FOR TREATMENT OF NEUROLOGICAL DISORDERS

#670
US20230270705A1
Human necessities

METHOD OF INCREASING THE POPULATION OF DIALISTER SPP. IN THE GUT MICROBIOME

#671
US20230270706A1
Human necessities

TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS

#672
US20230270707A1
Human necessities

ORAL LIQUID PHARMACEUTICAL COMPOSITIONS OF ISOTRETINOIN

#673
US20230270708A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING HOMOCYSTINURIA AND OTHER CONDITIONS USING POLYAMINES

#674
US20230270709A1
Human necessities

ANTIVIRAL PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION

#675 ✅ Patent 11,986,453 granted on 2024-05-21
US20230270710A1
Human necessities

Stable pharmaceutical composition containing non-steroidal anti-inflammatory drug derivative

#676
US20230270711A1
Human necessities

Improved Anti-Hangover Composition, Its Preparation and Uses

#677
US20230270712A1
Human necessities

NOBILETIN COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF COVID-19 AND RELATED PATHOLOGIES

#678
US20230270713A1
Human necessities

Administration of Resiniferatoxin For Treatment of Bladder Pain or Bladder Cancer

#679
US20230270714A1
Human necessities

SALVINORIN COMPOSITIONS

#680 ✅ Patent 12,116,597 granted on 2024-10-15
US20230270715A1
Human necessities

Autophagy as a therapeutic target for intracranial aneurysm

#681
US20230270716A1
Human necessities

GLYCOPYRROLATE ORAL FILM AND IT'S PROCESS

#682
US20230270717A1
Human necessities

INTRATHECAL ADMINISTRATION OF LEVETIRACETAM

#683
US20230270718A1
Human necessities

METHODS OF TREATING DIABETIC KIDNEY DISEASE

#684 ✅ Patent 12,161,625 granted on 2024-12-10
US20230270719A1
Human necessities

Substituted pyrrolizine compounds and uses thereof

#685
US20230270720A1
Human necessities

MAVOGLURANT, A MGLUR5 ANTAGONIST, FOR USE IN THE TREATMENT IN THE REDUCTION OF OPIOID USE

#686
US20230270721A1
Human necessities

INHIBITION OF BAX-MEDIATED CELL DEATH BY ELTROMBOPAG

#687 ✅ Patent 12,194,025 granted on 2025-01-14
US20230270722A1
Human necessities

Pharmaceutical composition for oral administration of edaravone and method of administering same

#688
US20230270723A1
Human necessities

GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH HEPATIC IMPAIRMENT

#689
US20230270724A1
Human necessities

PDE3 inhibitors for treating viral infections

#690 ✅ Patent 12,343,332 granted on 2025-07-01
US20230270725A1
Human necessities

TREATMENT OF A BACTERIAL VAGINAL INFECTION

#691 ✅ Patent 12,161,632 granted on 2024-12-10
US20230270726A1
Human necessities

Compositions and methods of treating cardiac fibrosis with ifetroban

#692
US20230270727A1
Human necessities

USE OF VEGF INHIBITOR IN PREPARATION OF MEDICAMENT FOR TREATING HYPOXIA-RELATED DISEASES

#693 ✅ Patent 11,801,237 granted on 2023-10-31
US20230270728A1
Human necessities

Amorphous kinase inhibitor formulations and methods of use thereof

#694
US20230270729A1
Human necessities

USE OF N-PHENYLACETAMIDES HAVING P2X4 RECEPTOR ANTAGONISTIC ACTIVITY FOR TREATING CERTIAN OCULAR DISORDERS

#695
US20230270730A1
Human necessities

COMPOSITION CONTAINING ARYLAMIDE DERIVATIVE

#696
US20230270731A1
Human necessities

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

#697
US20230270732A1
Human necessities

BLOCKADE OF CHEMOKINE (C-C MOTIF) RECEPTOR 2 DURING FLUID RESUSCITATION

#698
US20230270733A1
Human necessities

PREVENTIVE, RELIEF OR THERAPEUTIC USE OF 2,3,5-SUBSTITUTED THIOPHENE COMPOUND AGAINST GASTROINTESTINAL STROMAL TUMOR

#699 ✅ Patent 12,070,455 granted on 2024-08-27
US20230270734A1
Human necessities

Thienopyrrole compounds

#700
US20230270735A1
Human necessities

TOPICAL FORMULATION

#701 ✅ Patent 12,138,255 granted on 2024-11-12
US20230270736A1
Human necessities

Pharmaceutical compositions of cabozantinib

#702
US20230270737A1
Human necessities

Therapeutic Agent for Mild Cognitive Impairment

#703
US20230270738A1
Human necessities

METHODS OF TREATING AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE

#704
US20230270739A1
Human necessities

Methods and Compositions for Treating Pain While Minimizing the Risk of Opioid Addiction

#705
US20230270740A1
Human necessities

COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS

#706 ✅ Patent 11,857,547 granted on 2024-01-02
US20230270741A1
Human necessities

Compositions and methods for opioid antagonist delivery

#707
US20230270742A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE AND METHODS OF USING THE SAME

#708
US20230270743A1
Human necessities

USE OF BTK INHIBITORS IN THE TREATMENT OF DISEASES

#709
US20230270744A1
Human necessities

Methods of Administering Elagolix

#710
US20230270745A1
Human necessities

METHODS OF TREATING HER2 POSITIVE CANCER WITH TUCATINIB IN COMBINATION WITH TRASTUZUMAB, A TAXANE, AND A VEGFR-2 ANTAGONIST

#711 ✅ Patent 12,036,224 granted on 2024-07-16
US20230270746A1
Human necessities

Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredient

#712 ✅ Patent 11,883,411 granted on 2024-01-30
US20230270747A1
Human necessities

Use of compound aprepitant in preparation of drug for preventing or treating African swine fever (ASF)

#713
US20230270748A1
Human necessities

COMBINATION OF A BCL-2 INHIBITOR AND A HYPOMETHYLATING AGENT FOR TREATING CANCERS, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF

#714
US20230270749A1
Human necessities

THERMO-SENSITIVE PERMEATION ENHANCING FORMULATIONS FOR DRUG DELIVERY

#715
US20230270750A1
Human necessities

CARBALDEHYDE OXIMES AS BUTYRYLCHOLINESTERASE REACTIVATORS

#716
US20230270751A1
Human necessities

BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION

#717
US20230270752A1
Human necessities

METHODS OF TREATING PHELAN MCDERMID SYNDROME USING FARNESYL DIBENZODIAZEPINONES

#718
US20230270753A1
Human necessities

COMBINATIONS OF GABAA ALPHA 5 AGONISTS AND SV2A INHIBITORS AND METHODS OF USING IN THE TREATMENT OF COGNITIVE IMPAIRMENT

#719
US20230270754A1
Human necessities

COMBINATION THERAPY FOR INHALATION ADMINISTRATION

#720
US20230270755A1
Human necessities

COMBINATION OF MEDICATIONS IN A PARENTERAL DOSAGE FORM FOR LONG-TERM ANAESTHESIA

#721
US20230270756A1
Human necessities

LIPOSOMAL FORMULATIONS FOR INHIBITING SARS-CoV-2 REPLICATION AND REDUCING LUNG INFLAMMATION

#722
US20230270757A1
Human necessities

PREPARATION METHOD OF SALFAPRODIL FREEZE-DRIED POWDER INJECTION, AND PRODUCT AND USE THEREOF

#723
US20230270758A1
Human necessities

PHARMACEUTICAL SUSPENSIONS FOR BISMUTH SUBSALICYLATES

#724
US20230270759A1
Human necessities

METHODS OF TREATMENT USING FUROSEMIDE

#725
US20230270760A1
Human necessities

COMPOSITIONS FOR THE IMPROVED TREATMENT OF ACNE AND RELATED DISORDERS

#726
US20230270761A1
Human necessities

IMMUNOMODULATORY, ORAL MICROBIOME ALTERING AND TISSUE REGENERATIVE ORAL CARE COMPOSITIONS AND METHODS OF USE IN THE PREVENTION AND TREATMENT OF PERIODONTAL AND PERI-IMPLANT DISEASES

#727
US20230270762A1
Human necessities

TOPICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS AND RELATED SKIN DISORDERS

#728
US20230270763A1
Human necessities

METHOD OF TREATING CORONOVIRUS INFECTIONS WITH CANNABINOIDS AND DERIVATIVES

#729
US20230270764A1
Human necessities

COMPOSITION COMPRISING CANNABINOIDS, TERPENES, AND FLAVONOIDS FOR TREATING DEPRESSION

#730
US20230270765A1
Human necessities

APOTHECARIAL COMPOSITIONS AND RELATED METHODS OF TREATMENT

#731
US20230270766A1
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALS

#732
US20230270767A1
Human necessities

INHIBITORS OF ENPP1 AND METHODS OF USING SAME

#733 ✅ Patent 11,918,594 granted on 2024-03-05
US20230270768A1
Human necessities

Multi-substituent psilocybin derivatives and methods of using

#734 ✅ Patent 12,274,711 granted on 2025-04-15
US20230270769A1
Human necessities

Method of determining Acute Myeloid Leukemia response to treatment with farnesyltransferase inhibitors

#735
US20230270770A1
Human necessities

NUTRITIONAL SUPPLEMENTS FOR REPAIRING MUSCLE AND DEFENDING AGAINST DETERIORATION FROM HUMAN AGING

#736
US20230270771A1
Human necessities

LOW DOSE COMBINATION CDA SUBSTRATE DRUG/CEDAZURIDINE WITH EXTENDED ADMINISTRATION

#737
US20230270772A1
Human necessities

USE OF 5'-METHYLTHIOADENOSINE IN PREPARATION OF OBESITY-SUPPRESSING DRUGS OR HEALTH CARE PRODUCTS

#738
US20230270773A1
Human necessities

METHODS OF TREATING CANCER WITH A STING AGONIST

#739
US20230270774A1
Human necessities

TAU MODULATORS AND METHODS AND COMPOSITIONS FOR DELIVERY THEREOF

#740
US20230270776A1
Human necessities

Method for Reducing Ototoxicity in Pediatric Patients Receiving Plantinum-Based Chemotherapy

#741 ✅ Patent 12,036,239 granted on 2024-07-16
US20230270777A1
Human necessities

Treatment of inflammatory bowel diseases through administration of enteric aerobization therapy

#742
US20230270778A1
Human necessities

ANTIVIRAL PHARMACEUTICAL COMPOSITION COMPRISING GRAPHENE NANOPARTICLES

#743
US20230270779A1
Human necessities

EXOSOME HYDROGEL FOR TREATING SEVERE RESPIRATORY DISEASES AND PREPARATION METHOD THEREOF

#744
US20230270780A1
Human necessities

INJECTION COMPOSITION CONTAINING ISOLATED MITOCHONDRIA, AND USE THEREOF

#745
US20230270781A1
Human necessities

TREATMENT OR PREVENTION OF PRO-INFLAMMATORY DISEASES OR CONDITIONS USING INDUCED REGULATORY T (ITREG) CELLS

#746
US20230270782A1
Human necessities

COMPOSITIONS AND METHODS TO TARGET ANTI-RH ANTIBODY

#747
US20230270783A1
Human necessities

IMMUNE SYSTEM RESTORATION BY CELL THERAPY

#748
US20230270784A1
Human necessities

ONCOLYTIC VIRUS BOOSTS T CELL RESPONSE FOR EFFECTIVE TIL THERAPY

#749
US20230270785A1
Human necessities

METHODS OF ADMINISTERING CHIMERIC ANTIGEN RECEPTOR IMMUNOTHERAPY

#750
US20230270786A1
Human necessities

BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA

#751
US20230270787A1
Human necessities

CELL SURFACE ANTIGEN OF ACTIVATED IMMUNE CELL AND VARIOUS USES THEREOF

#752
US20230270788A1
Human necessities

COMPOSITION FOR AUGMENTING STEMNESS AND USE THEREOF

#753
US20230270789A1
Human necessities

COMBINATORIAL CANCER IMMUNOTHERAPY

#754
US20230270790A1
Human necessities

PLURIPOTENT STEM CELLS EFFECTIVE FOR TREATMENT OF MOTOR NEURON DISEASE (MND)

#755
US20230270791A1
Human necessities

PLATELET LYSATE DERIVED FROM AUTOLOGOUS PLATELETS

#756
US20230270792A1
Human necessities

REDUCTION OF COVID-19 COAGULOPATHY AND OTHER INFLAMMATION-ASSOCIATED COAGULOPATHIES BY ADMINISTRATION OF FIBROBLASTS

#757
US20230270793A1
Human necessities

Dosage Unit Formulations Of Autologous Dermal Fibroblasts

#758
US20230270794A1
Human necessities

ACELLULAR SOFT TISSUE-DERIVED MATRICES AND METHODS FOR USING SAME

#759 ✅ Patent 12,329,784 granted on 2025-06-17
US20230270795A1
Human necessities

GUT MICROBIOTA AND TREATMENT OF CANCER

#760
US20230270796A1
Human necessities

PREPARATIONS OF AMMONIA OXIDIZING MICROORGANISMS AND RELATED PRODUCTS

#761
US20230270797A1
Human necessities

NOVEL STRAIN OF THE SPECIES LACTICASEIBADLLUS RHAMNOSUS, COMPOSITIONS THEREOF AND USE THEREOF IN THE TREATMENT OF GENITOURINARY INFECTIONS

#762
US20230270798A1
Human necessities

SYNBIOTIC COMPOSITION

#763
US20230270799A1
Human necessities

BIOMATERIAL COMPRISING BACTERIAL CELLULOSE AND PROBIOTICS AND USES THEREOF

#764
US20230270800A1
Human necessities

PROBIOTIC COMPOSITIONS AND THEIR USE TO MODULATE IMMUNE SYSTEMS

#765 ✅ Patent 11,826,391 granted on 2023-11-28
US20230270801A1
Human necessities

Antibacterial formulation comprising a mixture of bacteriophages; use and method for preventing or treating diseases caused by salmonella spp. in farm animals by oral administration of the formulation

#766
US20230270802A1
Human necessities

ANTIVIRAL PHARMACEUTICAL COMPOSITION

#767
US20230270803A1
Human necessities

MEDICAL APPARATUS WITH CANNABIS SATIVA L.

#768
US20230270804A1
Human necessities

ANTI-HYPERCHOLESTEROLEMIA COMPOSITION AND A METHOD OF MANUFACTURING THE SAME

#769
US20230270805A1
Human necessities

A COMPOSITION COMPRISING AN EXTRACT OF ALDER TREE OR THE ISOLATED COMPOUNDS THEREFROM FOR TREATING AND PREVENTING SKELETON MUSCLE-RELATED DISORDER AND THE USE THEREOF

#770
US20230270806A1
Human necessities

THC-FREE CANNABINOID CONCENTRATE, METHOD OF OBTAINING THE SAME AND USE THEREOF

#771
US20230270807A1
Human necessities

ANTIMICROBIAL COMPOSITIONS

#772 ✅ Patent 12,239,680 granted on 2025-03-04
US20230270808A1
Human necessities

Sleep disorder compositions and treatments thereof

#773
US20230270809A1
Human necessities

VETERINARY COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF PROTOZOAN DISEASES AND METHODS OF PREPARATION THEREOF

#774
US20230270810A1
Human necessities

VETERINARY COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF PROTOZOAN DISEASES AND METHODS OF PREPARATION THEREOF

#775
US20230270811A1
Human necessities

COMPOSITION FOR THE PREVENTION OR TREATMENT OF RESPIRATORY DISEASES CAUSED BY FINE DUST COMPRISING AGASTACHE RUGOSA AND LICORICE EXTRACT

#776
US20230270812A1
Human necessities

COMPOSITION TO BE USED FOR STRENGTHENING THE IMMUNE SYSTEM IN HUMAN AND ANIMAL TO ACQUIRE PAN-IMMUNITY

#777
US20230270813A1
Human necessities

TREATMENT OF CORONAVIRUS AND BACTERIAL INFECTION WITH HOUTTUYNIA CORDATA EXTRACT AND COMBINED HOUTTUYNIA CORDATA AND PHYLLANTHUS URINARIA

#778
US20230270814A1
Human necessities

COMBINATION PHARMACEUTICAL OF TEMOZOLOMIDE AND MUTANT IDH1 ENZYME INHIBITOR

#779
US20230270815A1
Human necessities

Apoptosis inducing peptide (SSTP1)

#780
US20230270816A1
Human necessities

COMBINATION OF ANTINEOPLASTIC ANTIBIOTICS AND BCL-2 INHIBITORS FOR THE TREATMENT OF NPM-1-DRIVEN ACUTE MYELOID LEUKEMIA (AML)

#781
US20230270817A1
Human necessities

VIMENTIN INHIBITORS

#782
US20230270818A1
Human necessities

TCF7L2 MEDIATED REMYELINATION IN THE BRAIN

#783 ✅ Patent 11,896,646 granted on 2024-02-13
US20230270819A1
Human necessities

Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof

#784
US20230270820A1
Human necessities

SCD83 FOR WOUND HEALING, HAIR GROWTH, AND SKIN AND HAIR CARE

#785
US20230270821A1
Human necessities

FORMULATIONS COMPRISING ACTRII POLYPEPTIDE VARIANTS

#786 ✅ Patent 12,318,430 granted on 2025-06-03
US20230270822A1
Human necessities

Methods of treating neutorpenia using G-CSF protein complex

#787
US20230270823A1
Human necessities

LONG-ACTING IL-15 AND USES THEREOF

#788
US20230270824A1
Human necessities

INTERFERON-BASED CANCER TREATMENT METHOD AND PHARMACEUTICAL COMPOSITION

#789
US20230270825A1
Human necessities

STAPLED OLEFIN CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS

#790
US20230270826A1
Human necessities

ANTIVIRAL USE OF LIRAGLUTIDE AND GEFITINIB

#791 ✅ Patent 12,109,252 granted on 2024-10-08
US20230270827A1
Human necessities

Systems, methods and products for minimizing tissue reactions and tissue injury at an infusion site

#792
US20230270828A1
Human necessities

COMPOSITION FOR USE IN THE TREATMENT OF VIRAL INFECTIONS

#793
US20230270829A1
Human necessities

USE OF BOTULINUM NEUROTOXIN IN THE TREATMENT OF SIALORRHEA

#794 ✅ Patent 11,883,474 granted on 2024-01-30
US20230270830A1
Human necessities

Microbiome protection from oral antibiotics

#795
US20230270831A1
Human necessities

METHODS FOR INDUCING SELECTIVE APOPTOSIS

#796
US20230270832A1
Human necessities

MAGEA1 IMMUNOGENIC PEPTIDES, BINDING PROTEINS RECOGNIZING MAGEA1 IMMUNOGENIC PEPTIDES, AND USES THEREOF

#797 ✅ Patent 12,090,197 granted on 2024-09-17
US20230270833A1
Human necessities

Modulation of replicative fitness by deoptimization of synonymous codons

#798 ✅ Patent 12,168,047 granted on 2024-12-17
US20230270834A1
Human necessities

Tuberculosis antigen cassettes

#799 ✅ Patent 12,350,324 granted on 2025-07-08
US20230270835A1
Human necessities

STREPTOCOCCAL VACCINES

#800
US20230270836A1
Human necessities

ZOONOTIC DISEASE RNA VACCINES

#801 ✅ Patent 12,115,216 granted on 2024-10-15
US20230270837A1
Human necessities

Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

#802
US20230270838A1
Human necessities

VACCINE COMPOSITIONS FOR INFLUENZA VIRUSES AND METHODS OF USE

#803
US20230270839A1
Human necessities

VACCINE COMPOSITIONS

#804
US20230270840A1
Human necessities

VIRAL GUIDE RNA DELIVERY

#805
US20230270841A1
Human necessities

CORONAVIRUS VACCINE

#806
US20230270842A1
Human necessities

COMPOSITIONS AND DEVICES FOR VACCINE RELEASE AND USES THEREOF

#807
US20230270843A1
Human necessities

Post-Exposure Vaccination Against Viral Respiratory Infections

#808
US20230270844A1
Human necessities

MULTIVALENT BETA-CORONAVIRUS VACCINES, THEIR DESIGNS AND USES

#809
US20230270845A1
Human necessities

TREATMENT AND PREVENTION OF CONDITIONS ASSOCIATED WITH RESPIRATORY DISEASES

#810 ✅ Patent 12,257,300 granted on 2025-03-25
US20230270846A1
Human necessities

Replication-competent controlled alpha-herpesvirus vectors and uses therefore

#811
US20230270847A1
Human necessities

Recombinant Viral Vector, Immunogenic Composition Comprising Same, and Uses

#812
US20230270848A1
Human necessities

PEPTIDE IMMUNOGENS AND FORMULATIONS THEREOF TARGETING MEMBRANE-BOUND IgE FOR TREATMENT OF IgE MEDIATED ALLERGIC DISEASES

#813
US20230270849A1
Human necessities

click OMVs

#814
US20230270850A1
Human necessities

HPV VACCINE

#815
US20230270851A1
Human necessities

METHODS FOR THE TREATMENT OF IDIOPATHIC ORBITAL INFLAMMATION AND RELATED CONDITIONS

#816 ✅ Patent 12,194,093 granted on 2025-01-14
US20230270852A1
Human necessities

Dosing parameters for CD47 targeting therapies to hematologic malignancies

#817
US20230270853A1
Human necessities

INHIBITORS OF EPHRIN B1 FOR TUMOR TREATMENT

#818
US20230270854A1
Human necessities

MODIFIED ANTIBODIES

#819
US20230270855A1
Human necessities

Genetically Modified T-Cells and PI3K/AKT Inhibitors For Cancer Treatment

#820
US20230270856A1
Human necessities

FUSION PROTEIN AND USE THEREOF

#821
US20230270857A1
Human necessities

COMPOSITIONS INCLUDING EX VIVO ARMED T CELLS WITH MULTI-SPECIFIC ANTIBODIES AND USES THEREOF

#822
US20230270858A1
Human necessities

NOVEL CO-STIMULATORY DOMAIN AND USE THEREOF

#823
US20230270859A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING LUPUS

#824
US20230270860A1
Human necessities

MODIFIED MRNA FOR MULTICELL TRANSFORMATION

#825
US20230270861A1
Human necessities

Inhibitors of the Artemin Pathway for Treatment of Cancer

#826
US20230270862A1
Human necessities

COMPOSITIONS AND KITS FOR OMEPRAZOLE SUSPENSION

#827
US20230270863A1
Human necessities

ORAL PRODUCTS WITH REDUCED IRRITATION

#828
US20230270864A1
Human necessities

EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS

#829
US20230270865A1
Human necessities

LOW-DOSE PHARMACEUTICAL COMPOSITIONS OF GHRH ANALOGS AND USES THEREOF

#830
US20230270866A1
Human necessities

PHARMACEUTICAL COMPOSITION AND METHODS OF USES

#831
US20230270867A1
Human necessities

CONJUGATE IN WHICH FL118 DRUG IS LINKED TO ACID-SENSITIVE LINKER, AND IMMUNOCONJUGATE USING SAME

#832
US20230270868A1
Human necessities

PYRROLOBENZODIAZEPINE DIMER PRODRUG AND LIGAND-LINKER CONJUGATE COMPOUND OF THE SAME

#833 ✅ Patent 12,239,714 granted on 2025-03-04
US20230270869A1
Human necessities

Phosphatidylserine-binding conjugates

#834
US20230270870A1
Human necessities

DOSAGE OF AN ANTIBODY-DRUG CONJUGATE

#835
US20230270871A1
Human necessities

MARKERS FOR USE IN METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC)

#836
US20230270872A1
Human necessities

CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF

#837 ✅ Patent 11,833,217 granted on 2023-12-05
US20230270873A1
Human necessities

Muscle targeting complexes and uses thereof for treating dystrophinopathies

#838
US20230270874A1
Human necessities

ANTIBODY DRUG CONJUGATE LOADED WITH BINARY TOXINS AND ITS APPLICATION

#839
US20230270875A1
Human necessities

METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES

#840
US20230270876A1
Human necessities

SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES

#841
US20230270877A1
Human necessities

Combination Therapy

#842
US20230270878A1
Human necessities

DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2

#843
US20230270879A1
Human necessities

Anti-B7-H4 Antibodies And Methods

#844
US20230270880A1
Human necessities

SUPERPARAMAGNETISM-MODIFIED AND NEUTROPHIL EXOSOME BIOMIMETIC VESICLE-BASED BIOLOGICAL PREPARATION FOR DRUG DELIVERY, AND PREPARATION METHOD THEREOF

#845
US20230270881A1
Human necessities

ONCOGENIC TRIM37 IS A TARGETABLE EPIGENETIC DRIVER OF METASTASIS AND LINKS CHEMORESISTANCE AND METASTATIC FATE IN TRIPLE-NEGATIVE BREAST CANCER

#846
US20230270882A1
Human necessities

PEPTIDE-NANOPARTICLE CONJUGATES

#847
US20230270883A1
Human necessities

ACTIVE AGENT RELEASE PARTICLE

#848
US20230270884A1
Human necessities

COMPOSITIONS USEFUL FOR TREATMENT OF CHARCOT-MARIE-TOOTH DISEASE

#849
US20230270885A2
Human necessities

GENE THERAPY EXPRESSION SYSTEM ALLEVIATING CARDIAC TOXICITY OF FKRP

#850
US20230270886A1
Human necessities

MICRODYSTROPHIN GENE THERAPY CONSTRUCTS AND USES THEREOF

#851
US20230270887A1
Human necessities

ACTIVE DELIVERY OF NUCLEIC ACIDS AND PEPTIDES, METHODS AND USES

#852
US20230270888A1
Human necessities

SYNTHETIC DNA VECTORS AND METHODS OF USE

#853
US20230270889A1
Human necessities

Fluorescently-Traceable Amino Acid Derivative And Preparation Methods And Use Thereof

#854
US20230270890A1
Human necessities

FLUORESCENT COMPOUND FOR DETECTING BIOLOGICAL MATERIAL AND PREPARATION METHOD THEREOF

#855
US20230270891A1
Human necessities

Methods and Apparatuses for the Synthesis of Drug-Loaded Magnetic Micelle Aggregates

#856
US20230270892A1
Human necessities

CHELATOR COMPOSITIONS FOR RADIOMETALS AND METHODS OF USING SAME

#857
US20230270893A1
Human necessities

GALLIUM-LABELED GASTRIN ANALOGUE AND USE IN A METHOD OF IMAGING CCKB-RECEPTOR-POSITIVE TUMORS OR CANCERS

#858
US20230270894A1
Human necessities

RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING

#859
US20230270895A1
Human necessities

RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY

#860
US20230270896A1
Human necessities

SYSTEM AND METHOD OF ELIMINATING MICROORGANISMS

#861
US20230270897A1
Human necessities

TOXIC SUBJECT DECREASING/ELIMINATING DEVICE

#862
US20230270898A1
Human necessities

ULTRAVIOLET LIGHT IRRADIATION SYSTEM AND DECONTAMINATION METHOD

#863
US20230270899A1
Human necessities

SANITISING APPARATUS AND METHOD

#864
US20230270900A1
Human necessities

CLEANING KIT HAVING A SOLUTE

#865 ✅ Patent 12,010,997 granted on 2024-06-18
US20230270901A1
Human necessities

Systems, methods, and apparatuses for disinfection and decontamination

#866
US20230270902A1
Human necessities

SYSTEM AND METHOD FOR AUTOMATED VEHICLE SANITATION

#867 ✅ Patent 12,090,242 granted on 2024-09-17
US20230270903A1
Human necessities

Methods and devices for sterilizing medical equipment

#868 ✅ Patent 12,186,445 granted on 2025-01-07
US20230270904A1
Human necessities

Hand washing verification by contamination sensor

#869
US20230270905A1
Human necessities

ROBOT

#870
US20230270906A1
Human necessities

COUNTING UNIT

#871
US20230270907A1
Human necessities

ROOM REGION FOR AN AIRCRAFT, AIRCRAFT HAVING THE ROOM REGION, AND METHOD FOR DISINFECTING A SURFACE OF A ROOM REGION BY MEANS OF A DISINFECTING DEVICE

#872
US20230270908A1
Human necessities

APPARATUS FOR SEDIMENTATION AND OXIDATION OF FINE DUST AND AEROSOLS AND ORGANIC LOADS SUCH AS VIRUSES IN A DEVICE, AND FOR ELECTROSTATIC AND ELECTROCHEMICAL OR PHOTOCHEMICAL PROCESSESING OF THE AIR SUPPLIED BY THE DEVICE TO A ROOM FOR ANALOG PROCESSES IN THE ROOM

#873 ✅ Patent 12,016,980 granted on 2024-06-25
US20230270909A1
Human necessities

Scent warmer having sleeve for removably attaching decorative body to base and related methods

#874
US20230270910A1
Human necessities

Apparatus for dispensing a volatile substance, in particular an aroma or insectide, into ambient air

#875 ✅ Patent 12,102,740 granted on 2024-10-01
US20230270911A1
Human necessities

Pathogen mitigation

#876
US20230270912A1
Human necessities

PERACETIC ACID-BASED FORMULATION ASSOCIATED WITH A GRINDING PROCESS, THE COMBINATION OF WHICH TRANSFORMS CULTURES AND STRAINS OF BIOHAZARDOUS INFECTIOUS WASTE GENERATED IN THE PRODUCTION OF VACCINES IN OVO INTO RAW MATERIAL FOR THE PREPARATION OF HIGH-PROTEIN COMPOSTS

#877
US20230270913A1
Human necessities

MEDICAL POLYURETHANE FOAM DRESSING AND PREPARATION METHOD THEREOF

#878
US20230270914A1
Human necessities

HAEMOSTATIC MATERIAL

#879
US20230270915A1
Human necessities

CALCIUM-DEFICIENT SILICATE-SUBSTITUTED CALCIUM PHOSPHATE APATITE COMPOSITIONS AND METHODS

#880
US20230270916A1
Human necessities

COLLAGEN COMPOSITIONS AND USES FOR BIOMATERIAL IMPLANTS

#881
US20230270917A1
Human necessities

Method For Making Insertable Medical Devices With Low Profile Composite Coverings

#882 ✅ Patent 12,161,779 granted on 2024-12-10
US20230270918A1
Human necessities

Three-dimensional implantable matrix with reduced foreign body response

#883
US20230270919A1
Human necessities

IMPROVED MECHANICAL PROPERTIES OF IMPLANTABLE VASCULAR GRAFTS

#884 ✅ Patent 12,128,158 granted on 2024-10-29
US20230270920A1
Human necessities

Method of making an osteoconductive fibrous article and a medical implant comprising such osteoconductive fibrous article

#885
US20230270921A1
Human necessities

IMPLANTABLE MEDICAL DEVICE AND METHOD FOR MANUFACTURING SAME, AND METHOD FOR MANUFACTURING STENT

#886 ✅ Patent 12,246,119 granted on 2025-03-11
US20230270922A1
Human necessities

Patient line blockage detection

#887
US20230270923A1
Human necessities

BLOOD PURIFICATION APPARATUS

#888 ✅ Patent 12,090,259 granted on 2024-09-17
US20230270924A1
Human necessities

Wall box for hemodialysis interface

#889
US20230270925A1
Human necessities

BLOOD DIALYZING APPARATUS AND METHOD

#890
US20230270926A1
Human necessities

System and Methods Incorporating Replacement Fluid Maximization

#891
US20230270927A1
Human necessities

COMPOSITIONS, DEVICES AND METHODS FOR DIAGNOSING AND TREATING INFECTIOUS DISEASE

#892 ✅ Patent 12,042,595 granted on 2024-07-23
US20230270928A1
Human necessities

Continuous flow separation chamber

#893
US20230270929A1
Human necessities

SYSTEMS AND METHODS FOR INDUCING PLUG FLOW DURING FLUID SEPARATION USING AIR

#894
US20230270930A1
Human necessities

DRAINAGE DEVICE FOR DRAINING FLUIDS AND/OR WOUND SECRETION FROM THE THROAT AREA, NOSE AREA OR EAR AREA OF A PATIENT, IN PARTICULAR FOR USE AFTER A SURGICAL INTERVENTION IN THE CERVICAL AREA OF THE PATIENT OR IN NEUROLOGY

#895
US20230270931A1
Human necessities

SELF-POWERED FLUID WARMING CONTAINER AND FLUID WARMING DEVICE FOR USE IN A STERILE SURGICAL FIELD

#896 ✅ Patent 11,938,293 granted on 2024-03-26
US20230270932A1
Human necessities

Self-retaining enema nozzle and an enema system comprising said enema nozzle

#897
US20230270933A1
Human necessities

MEDICATION FLUID DELIVERY DEVICE

#898 ✅ Patent 12,208,237 granted on 2025-01-28
US20230270934A1
Human necessities

Rotationally biased insertion mechanism for a drug delivery pump

#899
US20230270935A1
Human necessities

CONTAINER ASSEMBLIES FOR CONTAINING AND DELIVERING MEDICAMENTS, AND METHODS OF FILLING SUCH ASSEMBLIES

#900
US20230270936A1
Human necessities

AMBULATORY INFUSION PUMPS AND ASSEMBLIES FOR USE WITH SAME